Literature DB >> 27678259

Copper Complexes of New Redox-Active 4,5-Bisguanidino-Substituted Benzodioxole Ligands: Control of the Electronic Structure by Counter-Ligands, Solvent, and Temperature.

David Fridolin Schrempp1, Elisabeth Kaifer1, Hubert Wadepohl1, Hans-Jörg Himmel2.   

Abstract

Herein, we analyze the possibility of controlling the electronic structure of mononuclear copper complexes featuring new redox-active 4,5-bisguanidino-substituted benzodioxole ligands. The nature of the guanidino groups, the anionic counter-ligands, the applied solvent (polarity), and the temperature are the parameters that decide if a CuII complex with neutral ligand unit or a CuI complex with radical monocationic ligand unit is the adequate description. Under special conditions, a temperature-dependent equilibrium of the two valence tautomeric forms (CuII /neutral ligand and CuI /radical monocationic ligand) is achieved. Removal of a ligand-centered electron from a paramagnetic CuII complex with a neutral ligand unit leads to a diamagnetic CuI complex with a dicationic ligand unit through a redox-induced electron-transfer (RIET) process.
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  copper complexes; electron transfer; electronic structures; redox-active ligands; valence tautomerism

Year:  2016        PMID: 27678259     DOI: 10.1002/chem.201602402

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  1,2,5,6-Tetrakis(guanidino)-Naphthalenes: Electron Donors, Fluorescent Probes and Redox-Active Ligands.

Authors:  Lukas Lohmeyer; Elisabeth Kaifer; Hubert Wadepohl; Hans-Jörg Himmel
Journal:  Chemistry       Date:  2020-04-21       Impact factor: 5.236

2.  Use of Crown Ether Functions as Secondary Coordination Spheres for the Manipulation of Ligand-Metal Intramolecular Electron Transfer in Copper-Guanidine Complexes.

Authors:  Sebastian Haaf; Elisabeth Kaifer; Hubert Wadepohl; Hans-Jörg Himmel
Journal:  Chemistry       Date:  2020-11-26       Impact factor: 5.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.